Article summary
What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West and Fletcher Burdick argue that safety, lineage, context, and individualized care cannot be separated so easily. The post Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols appeared first on Psychedelics Today.
Continue to the original publication for the complete article.